GTM · ZoomInfo Technologies Inc

The thesis

ZoomInfo Technologies is repositioning its business-contact data as the data layer under AI sales agents, but reported results do not yet show that shift: second-quarter 2026 revenue grew 1.2% and net revenue retention was 89%. The third-quarter report, now confirmed by the company for after the US close on 4 November 2026, settles whether agent products produce disclosed revenue.

The shares closed at $4.31 on 22 October 2026 (adjusted daily closes), up from $3.88 on 9 October 2026 and above the $4.20 close of 28 August 2026. They are up 39.9% over three months and sit 63.5% below the 52-week high of $11.80. The narrative is maturing: product news has run steadily since August, the latest being Agent Teams on 1 October 2026, and none of it has carried a revenue figure. The rating is unchanged; the price rise ahead of the report does not alter what the report must show.

Bullish and bearish views on ZoomInfo Technologies Inc

The bull case on ZoomInfo Technologies Inc (GTM), in brief: Agent products keep arriving. The bear case: Retention remains below 100%.

Bull case

• Agent products keep arriving. On 30 September 2026 ZoomInfo acquired DoubleO.ai, an agent-orchestration company, with terms undisclosed. On 1 October 2026 it launched Agent Teams in GTM Studio with no new contract required. Usage across existing customers could show up in reported numbers if adoption is broad.
• Guidance was raised in August. On 5 August 2026 ZoomInfo reported second-quarter revenue of $310.4 million against a $301.5 million analyst estimate (Benzinga) and lifted full-year revenue guidance to $1.207–1.217 billion from $1.185–1.205 billion. Third-quarter guidance of $298–301 million compares with a $293.7 million analyst estimate.
• Credit pricing gives agents a payment route. A 24 September 2026 Replit release says enrichment draws on bulk-data credits and research on AI credits. Reported credit consumption would be the first measured revenue link to agent usage.
• Cash generation is visible. Second-quarter operating cash flow was $87.3 million and adjusted operating income $110.0 million (8-K, 5 August 2026).
• Litigation overhang is being resolved. On 16 October 2026 ZoomInfo signed a memorandum of understanding to settle a securities class action for $44 million, partly funded by remaining insurance (8-K). The case covers purchases from 10 November 2020 to 5 August 2024.

Bear case

• Retention remains below 100%. Net revenue retention was 89% in the second quarter of 2026 (8-K, 5 August 2026). With revenue growth at 1.2%, existing customers are still shrinking their spend about as fast as new products add to it.
• Agent features may be bundled. Agent Teams requires no new contract (company release, 1 October 2026), which broadens reach but gives no separate revenue line.
• The balance sheet carries a large write-down and debt. The second quarter included a $650.5 million goodwill impairment and $1.27 billion of total debt (8-K, 5 August 2026).
• Analysts sit mostly below the share price. After the second-quarter report Citi kept Sell with a $2.50 target (7 August 2026), Stifel Hold at $4.00, and UBS and DA Davidson Neutral at $4.50 (6 August 2026). Wells Fargo had Underweight with a $3.00 target on 20 July 2026. The $4.31 close is above three of those five targets and below the two $4.50 targets.
• The settlement still needs court approval. The $44 million deal does not resolve the related shareholder derivative suits in Washington and Delaware or a separate direct action, according to the 16 October 2026 8-K.

Price setup

The shares closed at $4.31 on 22 October 2026 (adjusted daily closes). The 14-day relative strength index is 71.1, above the 70 line that conventionally marks an overbought reading. The close is above the $4.20 close of 28 August 2026, which had been the nearest overhead reference, and the next reference is the $4.50 level of the UBS and DA Davidson targets.

The 5 August 2026 post-results gap has held. Its lowest level, $3.66, sits below the last close and is the level whose loss would erase the August gain.

Crowding evidence is limited to price and the calendar. The shares are up 39.9% over three months into a report 13 days away, and the rise has come with a relative strength reading above 70. No insider sale or share issuance is reported in company news over the past 30 days.

Catalysts, next 30 days

No upcoming dated catalysts on file — the dated entries below have passed.

Elapsed catalysts

• 4 November 2026: Third-quarter 2026 results after the US close, with a call at 4:30 p.m. Eastern Time (company release, 14 October 2026). The report tests revenue against the $298–301 million guide, net revenue retention against 89%, and any disclosure of agent-product revenue or credit consumption. (passed 2d ago)
• Date not set: Court approval steps for the $44 million securities class action settlement (8-K, 16 October 2026). (passed 21d ago)

What would change the view

The case breaks if third-quarter revenue comes in under the $298 million lower bound of guidance, or if net revenue retention falls below the 89% reported in the second quarter. It also breaks if management reports no attributable revenue, seat or credit figure for its agent products after two months of launches.

On price, a daily close below $3.66 would erase the whole gain from the 5 August 2026 results gap. In the other direction, a quarter that discloses agent-product revenue and retention moving toward 100% would show the data-layer story reaching reported results.

What it trades with

ZoomInfo trades with application software shares that investors are marking down on fears that AI agents reduce paid seats, and with sales-technology peers whose growth has slowed. Its 2026 decline from the $11.80 high is tied to that debate and to its own low growth. Mizuho cut the stock to Underperform and Jefferies moved to Hold in May, citing weaker revenue expectations (Yahoo Finance report). A broad software rebound would lift the shares independently of agent revenue, which is why the 4 November 2026 figures matter more than the price move.